{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:48:10Z","timestamp":1783648090811,"version":"3.55.0"},"reference-count":168,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009148","name":"Queen Mary University of London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009148","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ecl.2020.05.005","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T16:51:02Z","timestamp":1596127862000},"page":"433-452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Update on the Genetics of Pituitary Tumors"],"prefix":"10.1016","volume":"49","author":[{"given":"Sayka","family":"Barry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rta","family":"Korbonits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2020.05.005_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","article-title":"Pangenomic classification of pituitary neuroendocrine tumors","volume":"37","author":"Neou","year":"2020","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.ecl.2020.05.005_bib2","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1158\/1078-0432.CCR-16-0790","article-title":"Landscape of genomic alterations in pituitary adenomas","volume":"23","author":"Bi","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ecl.2020.05.005_bib3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/cr.2016.114","article-title":"The genome-wide mutational landscape of pituitary adenomas","volume":"26","author":"Song","year":"2016","journal-title":"Cell Res"},{"key":"10.1016\/j.ecl.2020.05.005_bib4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/340692a0","article-title":"GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours","volume":"340","author":"Landis","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.ecl.2020.05.005_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-013-1354-5","article-title":"Epidemiology and etiopathogenesis of pituitary adenomas","volume":"117","author":"Aflorei","year":"2014","journal-title":"J\u00a0Neuroncol"},{"key":"10.1016\/j.ecl.2020.05.005_bib6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000182498","article-title":"G-protein oncogenes in acromegaly","volume":"38","author":"Spada","year":"1992","journal-title":"Horm Res"},{"key":"10.1016\/j.ecl.2020.05.005_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000345673","article-title":"Genetics of pituitary adenomas","volume":"41","author":"Gadelha","year":"2013","journal-title":"Front Horm Res"},{"key":"10.1016\/j.ecl.2020.05.005_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1023\/A:1006390306336","article-title":"Molecular basis of pituitary oncogenesis","volume":"45","author":"Tada","year":"1999","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.ecl.2020.05.005_bib9","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1177\/153537020322800904","article-title":"Genetics of pituitary tumors: focus on G-protein mutations","volume":"228","author":"Lania","year":"2003","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.ecl.2020.05.005_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-15-1064","article-title":"Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas","volume":"174","author":"Ronchi","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib11","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1172\/JCI11887","article-title":"Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly","volume":"107","author":"Hayward","year":"2001","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ecl.2020.05.005_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mce.2013.09.006","article-title":"Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma","volume":"386","author":"Zhou","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.tem.2012.11.007","article-title":"Novel pathway for somatostatin analogs in patients with acromegaly","volume":"24","author":"Gadelha","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11102-008-0136-0","article-title":"Prevalence of gsp oncogene in somatotropinomas and clinically non-functioning pituitary adenomas: our experience","volume":"12","author":"Taboada","year":"2009","journal-title":"Pituitary"},{"key":"10.1016\/j.ecl.2020.05.005_bib15","doi-asserted-by":"crossref","first-page":"e7427","DOI":"10.1590\/1414-431x20187427","article-title":"Study of major genetic factors involved in pituitary tumorigenesis and their impact on clinical and biological characteristics of sporadic somatotropinomas and non-functioning pituitary adenomas","volume":"51","author":"Foltran","year":"2018","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.ecl.2020.05.005_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/mp.55.1.58","article-title":"An R201H activating mutation of the GNAS1 (Gsalpha) gene in a corticotroph pituitary adenoma","volume":"55","author":"Riminucci","year":"2002","journal-title":"Mol Pathol"},{"key":"10.1016\/j.ecl.2020.05.005_bib17","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1210\/jc.2015-3129","article-title":"Whole-genome sequencing of growth hormone (GH)-secreting pituitary adenomas","volume":"100","author":"Valimaki","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib18","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1210\/jc.2013-3826","article-title":"Acromegaly and McCune-Albright syndrome","volume":"99","author":"Salenave","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl 4","key":"10.1016\/j.ecl.2020.05.005_bib19","first-page":"453","article-title":"McCune-Albright syndrome in adulthood","volume":"4","author":"Chanson","year":"2007","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.ecl.2020.05.005_bib20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ando.2010.02.015","article-title":"Ovarian dysfunction by activating mutation of GS alpha: McCune-Albright syndrome as a model","volume":"71","author":"Chanson","year":"2010","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib21","doi-asserted-by":"crossref","first-page":"E126","DOI":"10.1210\/jc.2012-2111","article-title":"Optic neuropathy in McCune-Albright syndrome: effects of early diagnosis and treatment of growth hormone excess","volume":"98","author":"Boyce","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng.3166","article-title":"Mutations in the deubiquitinase gene USP8 cause Cushing's disease","volume":"47","author":"Reincke","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.ecl.2020.05.005_bib23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/cr.2015.20","article-title":"Recurrent gain-of-function USP8 mutations in Cushing's disease","volume":"25","author":"Ma","year":"2015","journal-title":"Cell Res"},{"key":"10.1016\/j.ecl.2020.05.005_bib24","doi-asserted-by":"crossref","first-page":"OP2_01","DOI":"10.1055\/s-0035-1547607","article-title":"The ubiquitin-specific peptidase 8 (USP8) gene is frequently mutated in adenomas causing Cushing's disease","volume":"122","author":"Perez-Rivas","year":"2015","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ecl.2020.05.005_bib25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","article-title":"Epidermal growth factor receptor (EGFR) signaling in cancer","volume":"366","author":"Normanno","year":"2006","journal-title":"Gene"},{"key":"10.1016\/j.ecl.2020.05.005_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/EJE-15-0689","article-title":"The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease","volume":"174","author":"Hayashi","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11102-019-00973-9","article-title":"Cushing's disease due to somatic USP8 mutations: a systematic review and meta-analysis","volume":"22","author":"Wanichi","year":"2019","journal-title":"Pituitary"},{"key":"10.1016\/j.ecl.2020.05.005_bib28","doi-asserted-by":"crossref","first-page":"M73","DOI":"10.1530\/EJE-15-0320","article-title":"Decoding the genetic basis of Cushing's disease: USP8 in the spotlight","volume":"173","author":"Theodoropoulou","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12022-017-9474-7","article-title":"Pituitary carcinoma in a patient with an SDHB mutation","volume":"28","author":"Tufton","year":"2017","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.ecl.2020.05.005_bib30","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1210\/jc.2019-00697","article-title":"Germline USP8 mutation associated with pediatric Cushing disease and other clinical features: a new syndrome","volume":"104","author":"Cohen","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1530\/ERC-16-0082","article-title":"Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects","volume":"23","author":"Daly","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2020.05.005_bib32","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2015-4366","article-title":"Somatic GPR101 duplication causing X-linked acrogigantism (XLAG)-diagnosis and management","volume":"101","author":"Rodd","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40478-016-0328-1","article-title":"Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study","volume":"4","author":"Iacovazzo","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.ecl.2020.05.005_bib34","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa1408028","article-title":"Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation","volume":"371","author":"Trivellin","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2020.05.005_bib35","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s11102-016-0743-0","article-title":"Childhood acromegaly due to X-linked acrogigantism: long term follow-up","volume":"19","author":"Gordon","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.ecl.2020.05.005_bib36","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1210\/jc.2019-00817","article-title":"Familial X-linked acrogigantism: postnatal outcomes and tumor pathology in a prenatally diagnosed infant and his mother","volume":"104","author":"Wise-Oringer","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib37","doi-asserted-by":"crossref","first-page":"K15","DOI":"10.1530\/EJE-18-0778","article-title":"Germline and somatic mosaicism in a family with multiple endocrine neoplasia type 1 (MEN1) syndrome","volume":"180","author":"Beijers","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib38","first-page":"CC4","article-title":"Multiple endocrine neoplasia type 1 (MEN1) mosaicism caused by a c.124G>A variant in the MEN1 gene","volume":"65","author":"Mauchlen","year":"2019","journal-title":"Endocrine Abstracts"},{"key":"10.1016\/j.ecl.2020.05.005_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.beem.2010.07.003","article-title":"Multiple endocrine neoplasia type 1 (MEN1)","volume":"24","author":"Thakker","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000371819","article-title":"MEN1, MEN4, and Carney complex: pathology and molecular genetics","volume":"103","author":"Schernthaner-Reiter","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ecl.2020.05.005_bib42","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ecl.2020.05.005_bib43","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/6.7.1177","article-title":"Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1","volume":"6","author":"Lemmens","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ecl.2020.05.005_bib44","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","article-title":"Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study","volume":"87","author":"Verges","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib45","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0b013e31815ade45","article-title":"Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients","volume":"32","author":"Trouillas","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ecl.2020.05.005_bib46","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1210\/JC.2015-2015","article-title":"Long-term natural course of pituitary tumors in patients with MEN1: results from the DutchMEN1 study group (DMSG)","volume":"100","author":"de Laat","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib47","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-12-0763","article-title":"Genetic analysis in young patients with sporadic pituitary macroadenomas: beside AIP don't forget MEN1 genetic analysis","volume":"168","author":"Cuny","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib48","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ecl.2020.05.005_bib49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cancergen.2015.12.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1): an update of 208 new germline variants reported in the last nine years","volume":"209","author":"Concolino","year":"2016","journal-title":"Cancer Genet"},{"key":"10.1016\/j.ecl.2020.05.005_bib50","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1210\/jc.2017-00372","article-title":"Long-term natural course of small nonfunctional pancreatic neuroendocrine tumors in MEN1-results from the Dutch MEN1 Study Group","volume":"102","author":"Pieterman","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib51","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/archsurg.137.6.641","article-title":"Genotype-phenotype analysis in multiple endocrine neoplasia type 1","volume":"137","author":"Kouvaraki","year":"2002","journal-title":"Arch Surg"},{"key":"10.1016\/j.ecl.2020.05.005_bib52","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ecl.2020.05.005_bib53","doi-asserted-by":"crossref","first-page":"T195","DOI":"10.1530\/ERC-17-0243","article-title":"MEN4 and CDKN1B mutations: the latest of the MEN syndromes","volume":"24","author":"Alrezk","year":"2017","journal-title":"Endocrine Relat Cancer"},{"key":"10.1016\/j.ecl.2020.05.005_bib54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc2347","article-title":"The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy","volume":"8","author":"Chu","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ecl.2020.05.005_bib55","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1210\/jc.2006-2843","article-title":"Germline CDKN1B\/p27Kip1 mutation in multiple endocrine neoplasia","volume":"92","author":"Georgitsi","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib56","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib57","doi-asserted-by":"crossref","first-page":"E1825","DOI":"10.1002\/humu.21354","article-title":"A\u00a0novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization","volume":"31","author":"Molatore","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ecl.2020.05.005_bib58","doi-asserted-by":"crossref","first-page":"E701","DOI":"10.1210\/jc.2010-1338","article-title":"Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas","volume":"96","author":"Costa-Guda","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib59","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2265.2011.04269.x","article-title":"Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain","volume":"76","author":"Belar","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/ERC-11-0362","article-title":"Cyclin dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenomas (FIPA) kindreds","volume":"19","author":"Tichomirowa","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2020.05.005_bib61","doi-asserted-by":"crossref","first-page":"e1003350","DOI":"10.1371\/journal.pgen.1003350","article-title":"A\u00a0novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype","volume":"9","author":"Occhi","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ecl.2020.05.005_bib62","doi-asserted-by":"crossref","first-page":"K7","DOI":"10.1530\/EJE-14-0080","article-title":"A\u00a0heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome","volume":"171","author":"Tonelli","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib63","first-page":"510985","article-title":"Early onset primary hyperparathyroidism associated with a novel germline mutation in CDKN1B","volume":"2015","author":"Elston","year":"2015","journal-title":"Case Rep Endocrinol"},{"issue":"1","key":"10.1016\/j.ecl.2020.05.005_bib64","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12020-015-0540-y","article-title":"Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region","volume":"49","author":"Sambugaro","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.ecl.2020.05.005_bib65","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-198507000-00007","article-title":"The complex of myxomas, spotty pigmentation, and endocrine overactivity","volume":"64","author":"Carney","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ecl.2020.05.005_bib66","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1210\/jcem.86.9.7903","article-title":"Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation","volume":"86","author":"Stratakis","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib67","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/79238","article-title":"Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex","volume":"26","author":"Kirschner","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.ecl.2020.05.005_bib68","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1172\/JCI10841","article-title":"Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex","volume":"106","author":"Casey","year":"2000","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ecl.2020.05.005_bib69","doi-asserted-by":"crossref","first-page":"E183","DOI":"10.1210\/jc.2013-3159","article-title":"Deletions of the PRKAR1A locus at 17q24.2-q24.3 in Carney complex: genotype-phenotype correlations and implications for genetic testing","volume":"99","author":"Salpea","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib70","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1210\/jc.2017-01045","article-title":"Fatal Carney complex in siblings due to de novo large gene deletion","volume":"102","author":"Stelmachowska-Banas","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib71","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1158\/1078-0432.CCR-16-0452","article-title":"Novel genetic causes of pituitary adenomas","volume":"22","author":"Caimari","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ecl.2020.05.005_bib72","doi-asserted-by":"crossref","first-page":"M85","DOI":"10.1530\/EJE-15-0209","article-title":"Carney complex: an update","volume":"173","author":"Correa","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib73","doi-asserted-by":"crossref","first-page":"K7","DOI":"10.1530\/EJE-17-0227","article-title":"PRKAR1A mutation causing pituitary-dependent Cushing disease in a patient with Carney complex","volume":"177","author":"Kiefer","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib74","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/js.2017-00231","article-title":"Corticotropinoma as a component of Carney complex","volume":"1","author":"Hernandez-Ramirez","year":"2017","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.ecl.2020.05.005_bib75","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/jmg.40.4.268","article-title":"Chromosome 2 (2p16) abnormalities in Carney complex tumours","volume":"40","author":"Matyakhina","year":"2003","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.ecl.2020.05.005_bib76","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2020.05.005_bib77","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1530\/EJE-14-1154","article-title":"Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations","volume":"172","author":"Lodish","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib78","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMc1309730","article-title":"PRKACB and Carney complex","volume":"370","author":"Forlino","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2020.05.005_bib79","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EJE-14-0545","article-title":"Sequence analysis of the catalytic subunit of PKA in somatotroph adenomas","volume":"171","author":"Larkin","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib80","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1210\/er.2012-1013","article-title":"Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene","volume":"34","author":"Beckers","year":"2013","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.ecl.2020.05.005_bib81","doi-asserted-by":"crossref","first-page":"dgaa040","DOI":"10.1210\/clinem\/dgaa040","article-title":"Significant benefits of AIP testing and clinical screening in familial isolated and young-onset pituitary tumors","volume":"105","author":"Marques","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib82","author":"Stiles"},{"key":"10.1016\/j.ecl.2020.05.005_bib83","doi-asserted-by":"crossref","first-page":"E373","DOI":"10.1210\/jc.2009-2556","article-title":"Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study","volume":"95","author":"Daly","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib84","series-title":"GeneReviews","article-title":"AIP-related familial isolated pituitary adenomas","author":"Korbonits","year":"2020"},{"key":"10.1016\/j.ecl.2020.05.005_bib85","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1210\/jc.2019-00432","article-title":"Surgery, octreotide, temozolomide, bevacizumab, radiotherapy, and pegvisomant treatment of an AIP mutation positive child","volume":"104","author":"Dutta","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib86","doi-asserted-by":"crossref","first-page":"L11","DOI":"10.1530\/ERC-13-0218","article-title":"Familial pituitary apoplexy as the only presentation of a novel AIP mutation","volume":"20","author":"Xekouki","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2020.05.005_bib87","doi-asserted-by":"crossref","first-page":"E1242","DOI":"10.1210\/jc.2015-1869","article-title":"Landscape of familial isolated and young-onset pituitary adenomas: prospective diagnosis in AIP mutation carriers","volume":"100","author":"Hernandez-Ramirez","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib88","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000322787","article-title":"Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53","volume":"94","author":"Kasuki Jomori de","year":"2011","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ecl.2020.05.005_bib89","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1038\/s41388-019-0779-5","article-title":"Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors","volume":"38","author":"Barry","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.ecl.2020.05.005_bib90","doi-asserted-by":"crossref","first-page":"E1411","DOI":"10.1210\/jc.2012-1111","article-title":"Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway","volume":"97","author":"Chahal","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib91","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EJE-12-0457","article-title":"Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues","volume":"168","author":"Oriola","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib92","series-title":"Genetics of endocrine diseases and syndromes","first-page":"171","article-title":"Genetics of pituitary tumours","author":"Loughrey","year":"2019"},{"key":"10.1016\/j.ecl.2020.05.005_bib93","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mce.2010.05.001","article-title":"AIP gene and familial isolated pituitary adenomas","volume":"326","author":"Ozfirat","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib94","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.1126100","article-title":"Pituitary adenoma predisposition caused by germline mutations in the AIP gene","volume":"312","author":"Vierimaa","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ecl.2020.05.005_bib95","first-page":"249","article-title":"Loss of heterozygosity on chromosome 11q13 in two families with acromegaly\/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene","volume":"84","author":"Gadelha","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib96","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1677\/ERC-08-0287","article-title":"Genome-wide scan identifies novel modifier loci of acromegalic phenotypes for isolated familial somatotropinoma","volume":"16","author":"Khoo","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2020.05.005_bib97","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/EJE-15-1044","article-title":"Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas","volume":"174","author":"Lecoq","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib98","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1210\/jc.2007-2611","article-title":"The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas","volume":"93","author":"Leontiou","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib99","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1530\/JOE-17-0254","article-title":"AIP and the somatostatin system in pituitary tumours","volume":"235","author":"Ibanez-Costa","year":"2017","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib100","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1677\/ERC-09-0094","article-title":"Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications","volume":"16","author":"Jaffrain-Rea","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2020.05.005_bib101","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/sj.bjc.6603573","article-title":"Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers","volume":"96","author":"Georgitsi","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ecl.2020.05.005_bib102","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1677\/ERC-07-0025","article-title":"No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia","volume":"14","author":"Raitila","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2020.05.005_bib103","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1530\/EJE-11-0304","article-title":"High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas","volume":"165","author":"Tichomirowa","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib104","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/jmedgenet-2017-105191","article-title":"In\u00a0vivo bioassay to test the pathogenicity of missense human AIP variants","volume":"55","author":"Aflorei","year":"2018","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.ecl.2020.05.005_bib105","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/s41467-017-01704-z","article-title":"AIP limits neurotransmitter release by inhibiting calcium bursts from the ryanodine receptor","volume":"8","author":"Chen","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.ecl.2020.05.005_bib106","doi-asserted-by":"crossref","first-page":"35924","DOI":"10.1074\/jbc.M705471200","article-title":"Deletion of the aryl hydrocarbon receptor-associated protein 9 leads to cardiac malformation and embryonic lethality","volume":"282","author":"Lin","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ecl.2020.05.005_bib107","doi-asserted-by":"crossref","first-page":"e25201","DOI":"10.1371\/journal.pone.0025201","article-title":"The immunophilin-like protein XAP2 is a negative regulator of estrogen signaling through interaction with estrogen receptor alpha","volume":"6","author":"Cai","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ecl.2020.05.005_bib108","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/JOE-11-0054","article-title":"AIP and its interacting partners","volume":"210","author":"Trivellin","year":"2011","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib109","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/onc.2014.50","article-title":"AIP inactivation leads to pituitary tumorigenesis through defective Galphai-cAMP signaling","volume":"34","author":"Tuominen","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ecl.2020.05.005_bib110","doi-asserted-by":"crossref","first-page":"9177","DOI":"10.18632\/oncotarget.24183","article-title":"Multi-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland","volume":"9","author":"Hernandez-Ramirez","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ecl.2020.05.005_bib111","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1083\/jcb.200305051","article-title":"AIP is a mitochondrial import mediator that binds to both import receptor Tom20 and preproteins","volume":"163","author":"Yano","year":"2003","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.ecl.2020.05.005_bib112","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1210\/jc.2008-1980","article-title":"The tyrosine kinase receptor RET interacts in\u00a0vivo with aryl hydrocarbon receptor-interacting protein to alter survivin availability","volume":"94","author":"Vargiolu","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib113","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1074\/jbc.M509036200","article-title":"Regulation of transactivation function of the aryl hydrocarbon receptor by the Epstein-Barr virus-encoded EBNA-3 protein","volume":"281","author":"Kashuba","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ecl.2020.05.005_bib114","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mce.2014.05.004","article-title":"cAMP signalling in the normal and tumorigenic pituitary gland","volume":"392","author":"Formosa","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib115","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1530\/ERC-15-0205","article-title":"cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors","volume":"23","author":"Bolger","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2020.05.005_bib116","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/humu.21292","article-title":"Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families","volume":"31","author":"Igreja","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ecl.2020.05.005_bib117","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.2353\/ajpath.2010.100138","article-title":"Mice with inactivation of aryl hydrocarbon receptor-interacting protein (Aip) display complete penetrance of pituitary adenomas with aberrant ARNT expression","volume":"177","author":"Raitila","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ecl.2020.05.005_bib118","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/js.2016-1004","article-title":"Somatotroph-specific Aip-deficient mice display pretumorigenic alterations in cell-cycle signaling","volume":"1","author":"Gillam","year":"2017","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.ecl.2020.05.005_bib119","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1530\/ERC-15-0038","article-title":"X-linked acrogigantism syndrome: clinical profile and therapeutic responses","volume":"22","author":"Beckers","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2020.05.005_bib120","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMc1500340","article-title":"Gigantism, acromegaly, and GPR101 mutations","volume":"372","author":"Kamenicky","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2020.05.005_bib121","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI131609","article-title":"GPR101 mediates the pro-resolving actions of RvD5n-3 DPA in arthritis and infections","volume":"130","author":"Flak","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ecl.2020.05.005_bib122","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ghir.2016.09.007","article-title":"Gigantism: X-linked acrogigantism and GPR101 mutations","volume":"30-31","author":"Iacovazzo","year":"2016","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.ecl.2020.05.005_bib123","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/ERC-15-0478","article-title":"GHRH excess and blockade in X-LAG syndrome","volume":"23","author":"Daly","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2020.05.005_bib124","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1530\/JOE-18-0446","article-title":"Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects","volume":"240","author":"Pepe","year":"2019","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib125","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1530\/ERC-15-0320","article-title":"Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients","volume":"22","author":"Rostomyan","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2020.05.005_bib126","doi-asserted-by":"crossref","first-page":"R235","DOI":"10.1530\/EJE-19-0602","article-title":"Somatic and germline mutations in the pathogenesis of pituitary adenomas","volume":"181","author":"Vandeva","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib127","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.beem.2018.02.004","article-title":"An orphan G-protein-coupled receptor causes human gigantism and\/or acromegaly: molecular biology and clinical correlations","volume":"32","author":"Trivellin","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib128","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1055\/s-0042-100733","article-title":"GPR101 mutations are not a frequent cause of congenital isolated growth hormone deficiency","volume":"48","author":"Castinetti","year":"2016","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ecl.2020.05.005_bib129","series-title":"GeneReviews","article-title":"DICER1-Related disorders","author":"Doros","year":"2020"},{"key":"10.1016\/j.ecl.2020.05.005_bib130","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1158\/1078-0432.CCR-17-3089","article-title":"DICER1 and associated conditions: identification of at-risk individuals and recommended surveillance strategies","volume":"24","author":"Schultz","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ecl.2020.05.005_bib131","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/modpathol.2013.242","article-title":"DICER1 mutations in childhood cystic nephroma and its relationship to DICER1-renal sarcoma","volume":"27","author":"Doros","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ecl.2020.05.005_bib132","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-014-1285-z","article-title":"Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations","volume":"128","author":"de Kock","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ecl.2020.05.005_bib133","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00401-008-0388-9","article-title":"Pituitary blastoma","volume":"116","author":"Scheithauer","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ecl.2020.05.005_bib134","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.molmed.2012.07.003","article-title":"Exploring the endocrine manifestations of DICER1 mutations","volume":"18","author":"Choong","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ecl.2020.05.005_bib135","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg2843","article-title":"The widespread regulation of microRNA biogenesis, function and decay","volume":"11","author":"Krol","year":"2010","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ecl.2020.05.005_bib136","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2010.1910","article-title":"DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors","volume":"305","author":"Rio","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2020.05.005_bib137","doi-asserted-by":"crossref","first-page":"E1487","DOI":"10.1210\/jc.2014-1016","article-title":"Germline and somatic DICER1 mutations in a pituitary blastoma causing infantile-onset Cushing's disease","volume":"99","author":"Sahakitrungruang","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib138","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1158\/1078-0432.CCR-17-0629","article-title":"PTEN, DICER1, FH, and their associated tumor susceptibility syndromes: clinical features, genetics, and surveillance recommendations in childhood","volume":"23","author":"Schultz","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ecl.2020.05.005_bib139","doi-asserted-by":"crossref","first-page":"214","DOI":"10.12688\/f1000research.6746.1","article-title":"Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma\/DICER1 syndrome: a unique variant of the two-hit tumor suppression model","volume":"4","author":"Brenneman","year":"2015","journal-title":"F1000Res"},{"key":"10.1016\/j.ecl.2020.05.005_bib140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jmedgenet-2015-103428","article-title":"High-sensitivity sequencing reveals multi-organ somatic mosaicism causing DICER1 syndrome","volume":"53","author":"de Kock","year":"2016","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.ecl.2020.05.005_bib141","article-title":"DICER1 mutation and pituitary prolactinoma","volume":"2018","author":"Cotton","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.ecl.2020.05.005_bib142","doi-asserted-by":"crossref","first-page":"E710","DOI":"10.1210\/jc.2014-4297","article-title":"Pituitary adenoma with paraganglioma\/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice","volume":"100","author":"Xekouki","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib143","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/PAS.0000000000000149","article-title":"Succinate dehydrogenase deficiency is rare in pituitary adenomas","volume":"38","author":"Gill","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ecl.2020.05.005_bib144","doi-asserted-by":"crossref","first-page":"E531","DOI":"10.1210\/jc.2014-3399","article-title":"Heterogeneous genetic background of the association of pheochromocytoma\/paraganglioma and pituitary adenoma: results from a large patient cohort","volume":"100","author":"D\u00e9nes","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib145","first-page":"18","article-title":"A\u00a0patient with a germline SDHB mutation presenting with an isolated pituitary macroprolactinoma","volume":"2018","author":"Maher","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.ecl.2020.05.005_bib146","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/cen.13246","article-title":"Outcomes of annual surveillance imaging in an adult and paediatric cohort of succinate dehydrogenase B mutation carriers","volume":"86","author":"Tufton","year":"2017","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib147","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2005-1862","article-title":"Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes","volume":"91","author":"Benn","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib148","doi-asserted-by":"crossref","first-page":"E357","DOI":"10.1210\/jc.2011-1179","article-title":"Succinate dehydrogenase (SDH) D subunit (SDHD) inactivation in a growth-hormone-producing pituitary tumor: a new association for SDH?","volume":"97","author":"Xekouki","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ecl.2020.05.005_bib149","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.endonu.2012.02.009","article-title":"Coexistence of a pituitary macroadenoma and multicentric paraganglioma: a strange coincidence","volume":"60","author":"Varsavsky","year":"2012","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.ecl.2020.05.005_bib150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2019.08.005","article-title":"3P association (3PAs): pituitary adenoma and pheochromocytoma\/paraganglioma. A heterogeneous clinical syndrome associated with different gene mutations","volume":"69","author":"Guerrero-Perez","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ecl.2020.05.005_bib151","doi-asserted-by":"crossref","first-page":"C33","DOI":"10.1530\/ERC-12-0118","article-title":"Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and\/or Krebs cycle defects?","volume":"19","author":"Xekouki","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2020.05.005_bib152","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.mito.2010.03.001","article-title":"Succinate dehydrogenase: assembly, regulation and role in human disease","volume":"10","author":"Rutter","year":"2010","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ecl.2020.05.005_bib153","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ajhg.2017.03.011","article-title":"Germline mutations in CDH23, encoding cadherin-related 23, are associated with both familial and sporadic pituitary adenomas","volume":"100","author":"Zhang","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ecl.2020.05.005_bib154","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/83667","article-title":"Mutation of CDH23, encoding a new member of the cadherin gene family, causes Usher syndrome type 1D","volume":"27","author":"Bolz","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.ecl.2020.05.005_bib155","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1530\/ERC-17-0131","article-title":"Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing's disease","volume":"24","author":"Hernandez-Ramirez","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2020.05.005_bib156","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/jc.2015-3324","article-title":"The Cables1 gene in glucocorticoid regulation of pituitary corticotrope growth and Cushing disease","volume":"101","author":"Roussel-Gervais","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib157","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/me.2010-0091","article-title":"Cooperation between cyclin E and p27(Kip1) in pituitary tumorigenesis","volume":"24","author":"Roussel-Gervais","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib158","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ejim.2014.04.004","article-title":"Is it time to change the neurofibromatosis 1 diagnostic criteria?","volume":"25","author":"Tadini","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ecl.2020.05.005_bib159","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1474-4422(14)70255-8","article-title":"A\u00a0multidisciplinary approach in neurofibromatosis 1","volume":"14","author":"Milani","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ecl.2020.05.005_bib160","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41436-018-0312-1","article-title":"Growth hormone excess in neurofibromatosis 1","volume":"21","author":"Hannah-Shmouni","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.ecl.2020.05.005_bib161","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.mrrev.2008.06.001","article-title":"The mTOR pathway and its role in human genetic diseases","volume":"659","author":"Rosner","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.ecl.2020.05.005_bib162","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1507\/endocrj.EJ19-0035","article-title":"Acromegaly caused by a somatotroph adenoma in patient with neurofibromatosis type 1","volume":"66","author":"Hozumi","year":"2019","journal-title":"Endocr J"},{"key":"10.1016\/j.ecl.2020.05.005_bib163","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1365-2265.2005.02374.x","article-title":"Simultaneous Cushing's disease and tuberous sclerosis; a potential role for TSC in pituitary ontogeny","volume":"63","author":"Tigas","year":"2005","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib164","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2265.2007.02941.x","article-title":"Cushing's syndrome due to a pituitary corticotropinoma in a child with tuberous sclerosis: an association or a coincidence?","volume":"67","author":"Nandagopal","year":"2007","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ecl.2020.05.005_bib165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1677\/ERC-08-0142","article-title":"Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review","volume":"16","author":"Dworakowska","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ecl.2020.05.005_bib166","article-title":"Silent gonadotroph pituitary neuroendocrine tumor in a patient with tuberous sclerosis complex: evaluation of a possible molecular link","volume":"2018","author":"Regazzo","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.ecl.2020.05.005_bib167","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2013-2868","article-title":"Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation","volume":"99","author":"Williams","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2020.05.005_bib168","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852920300323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852920300323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:46:49Z","timestamp":1760176009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852920300323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":168,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0889852920300323"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2020.05.005","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on the Genetics of Pituitary Tumors","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2020.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}